首页 > 市场调查报告书 > 製药

生物标记

市场调查报告书

商品编码

1508759

神经生物标记市场：按生物标记类型、按应用、按最终用户、按地区

Neurological Biomarkers Market, By Biomarker Type, By Application, By End User, By Geography

出版日期: 2024年06月12日 | 出版商:

Coherent Market Insights | 英文 174 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球神经生物标记市场规模为85.1亿美元，预计2031年将达201亿美元，2024年至2031年复合年增长率为13.1%。

图 1. 2024 年按地区分類的神经生物标记物市场占有率(%)

神经生物标记有助于客观测量和评估正常的生物和病理过程。这些生物标记物可以帮助检测神经系统疾病、评估风险、追踪疾病进展并测量对治疗性介入的反应。阿兹海默症、帕金森氏症和多发性硬化症等神经系统疾病的发生率不断增加，可能会推动对可靠神经生物标记的需求。此外，对神经系统疾病精准医学和伴同性诊断开发的日益关注也推动了市场成长。然而，对疾病生物学的了解有限以及对生物标记的使用缺乏共识对市场成长构成了挑战。

市场动态：

神经系统生物标记的全球市场成长主要是由全球神经系统疾病盛行率上升所推动的。根据世界卫生组织的资料，神经系统疾病影响全球超过10亿人，使其成为全球疾病负担的主要来源。不断增长的老年人口更容易感染这些疾病，可能会增加需求。製药公司增加对生物标记研究和药物开发的投资可能会推动市场成长。然而，从标靶识别到商业化的高昂药物开发成本阻碍了生物标记进入新兴市场。关于生物标记在诊断和临床决策中的使用缺乏共识可能会阻碍市场成长。加强跨学科研究的公私合作可能为市场成长提供机会。

本研究的主要特点

该报告对全球神经生物标记市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球神经生物标记物市场的主要企业。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球神经生物标誌物市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

公司简介
- Thermo Fisher Scientific Inc.
- Merck &Co., Inc.
- Bio-Rad Laboratories, Inc.
- AbbVie Inc.
- QIAGEN NV
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- Myriad RBM
- Quanterix Corporation
- PerkinElmer Inc.
- Fujirebio
- Alzheon, Inc.
- Diagenic ASA
- Psynova Neurotech Ltd
- Banyan Biomarkers, Inc.
- Cisbio Bioassays
- Athena Diagnostics
- Immuno-Biological Laboratories Co., Ltd.

第10章分析师建议

升起和降落
综合机会图

第11章章节

参考
调查方法

简介目录

Product Code: CMI4586

Global neurological biomarkers market is estimated to be valued at USD 8.51 Bn in 2024 and is expected to reach USD 20.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) 13.1% from 2024 to 2031.

Figure 1. Neurological Biomarkers Market Share (%), By Region, 2024

Neurological biomarkers help in objectively measuring and evaluating normal biological and pathogenic processes. These aid in detecting neurological disorders, assessing risk, tracking disease progression, and measuring response to therapeutic interventions. Rising incidence of neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and others can boost demand for reliable neurological biomarkers. Furthermore, growing focus on development of precision medicine and companion diagnostics for neurological conditions can drive the market growth. However, limited understanding of disease biology and lack of consensus on use of biomarkers can pose challenge to market growth.

Market Dynamics:

Global neurological biomarkers market growth is primarily driven by rising prevalence of neurological disorders globally. According to the data from WHO, neurological disorders affect over a billion people worldwide with neurological conditions being a major contributor to the global burden of disease. Growing geriatric population, prone to these disorders, can boost demand. Higher investments in biomarker research and drug development by pharmaceutical players can drive the market growth. However, high cost of drug development from target identification to commercialization hampers newer biomarkers from entering the market. Lack of consensus on use of biomarkers in diagnosis and clinical decision-making can hamper the market growth. Increasing public private collaborations for interdisciplinary research can offer market growth opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global neurological biomarkers market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neurological biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Qiagen, Thermo Fisher Scientific and Abbott Laboratories
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global neurological biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation-

By Biomarker Type:
- Artificial Tears
- Imaging Biomarkers
- Metabolomics Biomarkers
- Proteomic Biomarkers
- Genomics Biomarkers
By Application
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
- Autism Spectrum Disorders
- Others
By End User
- Hospital Laboratories
- Clinical Diagnostic Centers
- Research Organizations
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Thermo Fisher Scientific Inc.
- Merck & Co., Inc.
- Bio-Rad Laboratories, Inc.
- AbbVie Inc.
- QIAGEN N.V.
- Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- Myriad RBM
- Quanterix Corporation
- PerkinElmer Inc.
- Fujirebio
- Alzheon, Inc.
- Diagenic ASA
- Psynova Neurotech Ltd
- Banyan Biomarkers, Inc.
- Cisbio Bioassays
- Athena Diagnostics
- Immuno-Biological Laboratories Co., Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Biomarker Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Neurological Biomarkers Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Neurological Biomarkers Market, By Biomarker Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Artificial Tears
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Imaging Biomarkers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Metabolomics Biomarkers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Proteomic Biomarkers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Genomics Biomarkers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Neurological Biomarkers Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Alzheimer's Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parkinson's Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Multiple Sclerosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Autism Spectrum Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Neurological Biomarkers Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical Diagnostic Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Research Organizations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Neurological Biomarkers Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bio-Rad Laboratories, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- QIAGEN N.V.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- F. Hoffmann-La Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Siemens Healthineers AG
- Myriad RBM
- Quanterix Corporation
- PerkinElmer Inc.
- Fujirebio
- Alzheon, Inc.
- Diagenic ASA
- Psynova Neurotech Ltd
- Banyan Biomarkers, Inc.
- Cisbio Bioassays
- Athena Diagnostics
- Immuno-Biological Laboratories Co., Ltd.

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

神经生物标记市场：按生物标记类型、按应用、按最终用户、按地区